Institut Paoli-calmettes

This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before surgery can improve outcomes for people with HER2-negative inflammatory breast cancer, a rare and aggressive type. About 52 adults will receive either chemo alone or chemo plus pe…

This study is looking at two substances in the blood, called MMP2 and MMP9, to see if they can predict how well certain drugs work for people with advanced kidney cancer. Researchers will measure these markers in 50 patients who are starting treatment with Sunitinib or Pazopanib,…

This study looks at tumor and blood samples from 115 people with a common type of advanced breast cancer (HR+/HER2-). The goal is to find genetic markers that predict whether a combination of hormone therapy and a targeted drug (ribociclib) will work. By comparing samples taken b…

This study collects tissue and blood samples from 300 women with suspected ovarian, endometrial, or cervical cancer. Researchers analyze genes and proteins to find patterns that may predict how the cancer behaves. The goal is to improve future diagnosis and treatment, not to test…